[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$cybin

Cybin's CYB003 is gaining attention for its potential advantages over competitors, with discussions highlighting its faster action and potential for broader insurance coverage. Mentions and engagements are up, indicating growing interest in the company's developments.

About $cybin

Cybin (CYBN) is a biotechnology company focused on the research and development of psychedelic-based therapeutics.

Insights #

$cybin mentions is at XX which is XXX% higher than it's daily average.
$cybin mentions near a 52-week high at XX.
$cybin engagements is up XXXXXX% from the previous week.
$cybin posts created is up XXX% from the previous week.
$cybin Mentions hit a high of XX for the day
$cybin Mentions hit an all time of XX for the day

Engagements: XX #

Engagements Line Chart
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXXXX +917%
6 Months: XXXXXX +1,574%
1 Year: XXXXXX +581%
1-Year High: XXXXXX on 2025-02-14
1-Year Low: X on 2024-11-24

Social Network	X
Engagements	XX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
6 Months: XX +300%
1 Year: XX no change
1-Year High: XX on 2025-07-24
1-Year Low: X on 2024-09-20

Social Network	X
Mentions	XX

Creators: X #

Creators Line Chart
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $cybin in the last XX hours which is up XXX% from X in the previous XX hours Daily Average: X
6 Months: X +75%
1 Year: XX +57%
1-Year High: X on 2025-02-14
1-Year Low: X on 2024-09-20

Sentiment: XXX% #

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1 Year: XXX% no change
1-Year High: XXX% on 2025-07-18
1-Year Low: XXX% on 2025-07-18

Most Supportive Themes

CYB003 Advantages: (40%) The posts highlight CYB003's advantages, including faster action and potential for broader insurance coverage, positioning it favorably against competitors.
Market Opportunity and IP: (30%) The posts emphasize Cybin's IP on compounds and first-mover advantage in a large total addressable market (TAM) for mental health treatments.
Faster Patient Reach: (15%) The posts highlight the potential of Cybin's shorter-duration, scalable model, and strong results in MDD, giving it a potential advantage in reaching more patients faster.

Most Critical Themes

Competitor Comparison: (15%) Mentions of competitors like COMPASS Pathways ($CMPS) and ATAI Life Sciences ($ATAI) are present, indicating a comparison of Cybin's ($CYBN) performance and potential.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XX	XX%	XX	XX%	X	X%

Total	XX	XX%	XX	XX%	X	X%

Top assets mentioned In the posts about $cybin in the last XX hours

ATAI Life Sciences (ATAI) ATAI Life Sciences (ATAI)

Top topics mentioned In the posts about $cybin in the last XX hours

$cmps, faster, compound, $atai, $mnmd, ip, $60b, $15b, $10b, iv, atai life, stocks bitcoin treasuries, has been, $20b, insurance